Courier Health Secures $50 Million Series B to Scale AI-Driven Patient Journey Platform

New updates have been reported about Courier Health.

Courier Health has raised $50 million in Series B financing led by Oak HC/FT, with continued backing from Norwest and Work-Bench, to accelerate development of its patient-experience platform for biopharma. The New York-based company plans to channel the capital into product innovation, expansion of its agentic AI capabilities, and team growth to meet rising demand from life sciences customers.

Courier Health’s software connects fragmented patient data and disparate support systems to give biopharma manufacturers end-to-end visibility and control over the patient journey, from education and enrollment through benefits verification, prior authorization, therapy initiation, and adherence. Its platform uses integrated data and context-aware AI to surface insights, flag at-risk patients, automate routine tasks via AI agents, and standardize interactions across providers, pharmacies, and patient services teams.

Founder and CEO Danny Sigurdson said the financing strengthens Courier Health’s ability to “re-write the patient experience” by simplifying complex treatment pathways for patients on innovative medicines, with success measured in improved outcomes rather than software metrics. Oak HC/FT partner Billy Deitch framed the company as core infrastructure that finally operationalizes “true patient-centricity” in life sciences, arguing that the sector has lacked a purpose-built system to manage prescribed patients at scale.

Courier Health posted rapid growth in 2025, increasing the number of customers and supported therapies on its platform by more than 400% and more than doubling headcount to support implementation and customer success. Management expects the new funding to extend this trajectory by broadening its customer base across chronic and rare diseases and deepening capabilities for market access and patient services teams.

The raise comes as most biopharma companies continue to struggle with siloed, inactionable data and limited AI readiness; the 2026 State of Patient-Centricity report, published by Courier Health, found nearly 60% of firms view their data as fragmented and fewer than 10% have sufficient maturity to leverage AI effectively. Against that backdrop, Courier Health is positioning its platform as a critical enabler of data-driven patient support programs that can deliver double-digit gains in therapy starts, speed-to-start, and adherence, with direct implications for manufacturers’ revenue, persistence, and real-world outcomes.